Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Completed 4

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 2

Conditions

Uveal Melanoma 2Macular Edema 2von Hippel-Lindau Disease 1Retinal Diseases 1Neoplasms 1Melanoma 1Glaucoma, Neovascular 1Conjunctival Neoplasms 1

Interventions

Paclitaxel 291Gemcitabine 254Carboplatin 253Cisplatin 250Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 180Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Ipilimumab 90Pemetrexed 89fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Completed × Ranibizumab × Clear all
NCT00456495 2017-07-21

Effect of Ranibizumab on Malignant Conjunctival Neoplasia

The New York Eye Cancer Center

Phase 1 Completed
5 enrolled 6 charts

Conjunctival Neoplasms

NCT00089765 2017-07-02

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
5 enrolled

von Hippel-Lindau Disease, Macular Edema, Neoplasms

NCT00765921 2016-12-02

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

Massachusetts Eye and Ear Infirmary

Phase 1 Completed
40 enrolled
Dermatologic

Uveal Melanoma, Macular Edema, Glaucoma, Neovascular

NCT00750399 2012-04-26

Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma

The New York Eye Cancer Center

Phase 1 Completed
10 enrolled
Dermatologic

Uveal Melanoma, Melanoma, Retinal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡